Prostate Cancer and Prostatic Diseases
ISSN 1365-7852 · Springer Nature · United Kingdom · active 1972–2026
Metrics
“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric. Citation rates differ enormously between fields, so compare within a discipline.
Indexing & access
Access status: unknown. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.
Scope
Frequently asked
Is Prostate Cancer and Prostatic Diseases a predatory journal?
Our screening does not flag Prostate Cancer and Prostatic Diseases. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in Scopus, Web of Science, PubMed, which is a positive signal.
Is Prostate Cancer and Prostatic Diseases indexed in Scopus or Web of Science?
Per our venue index, Prostate Cancer and Prostatic Diseases appears in: Scopus, Web of Science, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.
What is Prostate Cancer and Prostatic Diseases's impact?
Papers in Prostate Cancer and Prostatic Diseases are cited about 4.3 times each within two years of publication, and Scimago places it in Q1, with an h-index of 98. This is not a Clarivate Journal Impact Factor — we neither compute nor license that metric — and a citation rate is a property of a field as much as of a journal.
Is Prostate Cancer and Prostatic Diseases open access?
We hold no reliable open-access classification for Prostate Cancer and Prostatic Diseases. Check the journal's own site for its access model and any article processing charge.